ORTEXORTEX News

Articles

Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.

Trader Note — 15397 total

Trader NoteQTEC

QTEC shorts rebuild as tech ETF stages a 26% monthly surge

QTEC enters the first week of May in a striking position: short sellers have been aggressively adding exposure into one of the sharpest one-month rallies the First Trust NASDAQ-100 Technology Sector Index Fund has seen…

1 min read
Trader NoteQQEW

QQEW Options Sentiment Flips Bullish as Shorts Retreat

QQEW, the First Trust Nasdaq-100 Equal Weight ETF, closed at $140.17 on May 5 — up 2.8% on the week and nearly 10% over the past month — at the same time that options positioning has made a sharp pivot toward the…

1 min read
Trader NoteFPX

FPX Shorts Retreat as Options Traders Turn Bullish

FPX — the First Trust US Equity Opportunities ETF — is closing the week at $188.60, up over 7% in five sessions and nearly 16% over the past month. What makes the setup striking is not the rally itself but what the…

1 min read
Trader NoteVGK

Europe ETF Shorts Double as Options Traders Turn Defensive

VGK — the Vanguard FTSE Europe ETF — carries a striking split right now. Short interest has nearly doubled over the past month while the ETF itself gained 4.4%. Bearish positioning and rising prices are moving in…

1 min read
Trader NoteA005930

Samsung's $1 Trillion Moment Signals a KOSPI Re-rating

A005930 has just notched one of its most striking weeks in years, surging nearly 13% on May 6 alone as the KOSPI broke through 7,300 and Samsung reclaimed a $1 trillion market cap. The price tells the whole story: the…

1 min read
Trader NoteAD

Ahold Delhaize's CEO exit overshadows a solid earnings beat

Koninklijke Ahold Delhaize N.V. delivered a mixed Q1 result today — but the number that moved the conversation was not on the income statement. The retail giant reported adjusted EPS of $0.73 for the first quarter,…

1 min read
Trader NoteNOVO B

Novo Nordisk's earnings beat resets the story

NOVO B arrived at its Q1 2026 results carrying a bruised chart and a sceptical market — and then blew the doors off estimates. Q1 adjusted EPS came in at $1.04 against a consensus of $0.87. Sales reached $15.2 billion,…

1 min read
Trader NoteNICE

NICE beats on Q1 but guidance disappoints

NICE heads into the post-earnings session with a classic beat-and-guide-lower dynamic — strong Q1 numbers landing alongside Q2 revenue guidance that missed the Street, sending the stock down 3.3% on the day even after…

1 min read
Trader Note2330

TSMC Rebounds Sharply — But Shorts Have Already Retreated

Taiwan Semiconductor Manufacturing Company has clawed back 1.6% over the past week to TWD 2,250, recovering from the turbulence of early April — and the most telling detail is that short sellers appear to have given up…

1 min read